{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:07:55Z","timestamp":1765728475083},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T00:00:00Z","timestamp":1376352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s40256-013-0040-5","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T05:03:15Z","timestamp":1376283795000},"page":"425-433","source":"Crossref","is-referenced-by-count":21,"title":["Factors Associated with Undertreatment of Atrial Fibrillation in Geriatric Outpatients with Alzheimer Disease"],"prefix":"10.1007","volume":"13","author":[{"name":"the REAL.FR Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Tavassoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gillette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,13]]},"reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryd\u00e9n LE, Asinger RW, et al. ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation. 2001;104:2118\u201350.","journal-title":"Circulation"},{"key":"40_CR2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.177031","volume":"114","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryden LE, Cannom DS, et al. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation: executive summary. Circulation. 2006;114:700\u201352.","journal-title":"Circulation"},{"key":"40_CR3","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (2007). Guide\u2014affection de longue dur\u00e9e 2007: fibrillation auriculaire. http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/ald_5_fibrillation_auriculaire.pdf . Accessed 22 Jul 2013."},{"key":"40_CR4","doi-asserted-by":"crossref","unstructured":"Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. Eur Heart J. 2010;31:2369\u2013429.","DOI":"10.1093\/eurheartj\/ehq278"},{"key":"40_CR5","doi-asserted-by":"crossref","unstructured":"Tulner LR, Van Campen JP, Kuper IM, Gijsen GJ, Koks CH, Mac Gillavry MR, van Tinteren H, Beijnen JH, Brandjes DP. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging. 2010;27:39\u201350.","DOI":"10.2165\/11319540-000000000-00000"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0167-4943(01)00184-4","volume":"33","author":"S Vasishta","year":"2001","unstructured":"Vasishta S, Toor F, Johansen A, et al. Stroke prevention in atrial fibrillation: physicians\u2019 attitudes to anticoagulation in older people. Arch Gerontol Geriatr. 2001;33:219\u201326.","journal-title":"Arch Gerontol Geriatr"},{"key":"40_CR7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0002-8703(99)70006-2","volume":"138","author":"DW Baker","year":"1999","unstructured":"Baker DW, Hayes RP, Massie BM, et al. Variations in family physicians\u2019 and cardiologists\u2019 care for patients with heart failure. Am Heart J. 1999;138:826\u201334.","journal-title":"Am Heart J"},{"key":"40_CR8","first-page":"95","volume":"12","author":"HL Lipton","year":"1992","unstructured":"Lipton HL, Bero LA, Bird JA, et al. Undermedication among geriatric outpatients: results of a randomized controlled trial. Ann Rev Gerontol Ger. 1992;12:95\u2013108.","journal-title":"Ann Rev Gerontol Ger"},{"key":"40_CR9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1742-1241.2006.01241.x","volume":"61","author":"T Dinh","year":"2007","unstructured":"Dinh T, Nieuwlaat R, Tieleman RG, B\u00fcller HR, van Charante NA, Prins MH, Crijns HJ. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in the Netherlands\u2014the EXAMINE-AF study: a questionnaire survey. Int J Clin Pract. 2007;61:24\u201331.","journal-title":"Int J Clin Pract"},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2125.2004.02086.x","volume":"57","author":"D Deplanque","year":"2004","unstructured":"Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, De Reuck J, Mas JL, Gallai V, SAFE II Investigators. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol. 2004;57:798\u2013806.","journal-title":"Br J Clin Pharmacol"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00002512-200219110-00002","volume":"19","author":"G Chatap","year":"2002","unstructured":"Chatap G, Giraud K, Vincent JP. Atrial fibrillation in the elderly: facts and management. Drugs Aging. 2002;19:819\u201346.","journal-title":"Drugs Aging"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/01.STR.31.9.2266","volume":"21","author":"A Villa","year":"2000","unstructured":"Villa A, Bacchetta A, Omboni E, et al. Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation response. Stroke. 2000;21:2266\u201378.","journal-title":"Stroke"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2296-3-11","volume":"3","author":"L Ceresne","year":"2002","unstructured":"Ceresne L, Upshur RE. Atrial fibrillation in a primary care practice: prevalence and management. BMC Fam Prac. 2002;3:11.","journal-title":"BMC Fam Prac"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.54.1.4","volume":"54","author":"A Lobo","year":"2000","unstructured":"Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S4\u20139.","journal-title":"Neurology"},{"key":"40_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1532-5415.1996.tb01436.x","volume":"44","author":"WS Aronow","year":"1996","unstructured":"Aronow WS, Ahn C, Gutstein H. Prevalence of atrial fibrillation and association of atrial fibrillation with prior and new thromboembolic stroke in older patients. J Am Geriatr Soc. 1996;44:521\u20133.","journal-title":"J Am Geriatr Soc"},{"key":"40_CR16","first-page":"209","volume":"8","author":"E Duron","year":"2010","unstructured":"Duron E, Hanon O. Atrial fibrillation and cognitive function. Psychol Neuropsychiatr Vieil. 2010;8:209\u201314.","journal-title":"Psychol Neuropsychiatr Vieil"},{"key":"40_CR17","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/eurheartj\/ehm012","volume":"28","author":"Y Miyasaka","year":"2007","unstructured":"Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J. 2007;28:1962\u20137.","journal-title":"Eur Heart J"},{"key":"40_CR18","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archneur.59.10.1589","volume":"59","author":"SD Edland","year":"2002","unstructured":"Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59:1589\u201393.","journal-title":"Arch Neurol"},{"issue":"Suppl. 1","key":"40_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.archger.2007.01.023","volume":"44","author":"P Forti","year":"2007","unstructured":"Forti P, Maioli F, Pisacane N, Rietti E, Montesi F, Ravaglia G. Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment (MCI). Arch Gerontol Geriatr. 2007;44(Suppl. 1):155\u201365.","journal-title":"Arch Gerontol Geriatr"},{"key":"40_CR20","doi-asserted-by":"crossref","unstructured":"Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, Anand IS, Hart R, Connolly SJ; Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE) Investigators. Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010;3:277\u201383.","DOI":"10.1161\/CIRCOUTCOMES.109.884171"},{"key":"40_CR21","first-page":"91","volume":"7","author":"S Gillette-Guyonnet","year":"2003","unstructured":"Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. The REAL.FR research program on Alzheimer\u2019s disease and its management: methods and preliminary results. J Nutr Health Aging. 2003;7:91\u20136.","journal-title":"J Nutr Health Aging"},{"key":"40_CR22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"40_CR23","doi-asserted-by":"crossref","unstructured":"The definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. J Auton Nerv Syst. 1996;58:123\u20134.","DOI":"10.1016\/0165-1838(96)90001-6"},{"key":"40_CR24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914\u20139.","journal-title":"JAMA"},{"key":"40_CR25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist"},{"key":"40_CR26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1532-5415.1997.tb01479.x","volume":"45","author":"BJ Vellas","year":"1997","unstructured":"Vellas BJ, Wayne SJ, Romero L, Baumgartner RN, Rubenstein LZ, Garry PJ. One-leg balance is an important predictor of injurious falls in older persons. J Am Geriatr Soc. 1997;45:735\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"40_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0899-9007(98)00171-3","volume":"15","author":"B Vellas","year":"1999","unstructured":"Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15:116\u201322.","journal-title":"Nutrition"},{"key":"40_CR28","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0248-8663(02)00691-4","volume":"23","author":"A Tilly-Gentric","year":"2002","unstructured":"Tilly-Gentric A. Anticoagulation in permanent atrial fibrillation after 75\u00a0years of age. Rev Med Interne. 2002;23:834\u20139.","journal-title":"Rev Med Interne"},{"key":"40_CR29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","volume":"151","author":"BF Gage","year":"2006","unstructured":"Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151:713\u20139.","journal-title":"Am Heart J"},{"key":"40_CR30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archinte.160.7.967","volume":"160","author":"GP Samsa","year":"2000","unstructured":"Samsa GP, Matchar DB, Goldstein LB, Bonito AJ, Lux LJ, Witter DM, et al. Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. Arch Intern Med. 2000;160:967\u201373.","journal-title":"Arch Intern Med"},{"key":"40_CR31","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/01.STR.31.4.822","volume":"31","author":"BF Gage","year":"2000","unstructured":"Gage BF, Boechler M, Doggette AL, Fortune G, Flaker GC, Rich MW, et al. Adverse outcomes and predictors of underuse of antithrombotic therapy in Medicare beneficiaries with chronic atrial fibrillation. Stroke. 2000;31:822\u20137.","journal-title":"Stroke"},{"key":"40_CR32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.1997.00440300080006","volume":"157","author":"JH Gurwitz","year":"1997","unstructured":"Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long term care setting. Arch Intern Med. 1997;157:978\u201384.","journal-title":"Arch Intern Med"},{"key":"40_CR33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF02598985","volume":"11","author":"RJ Beyth","year":"1996","unstructured":"Beyth RJ, Antani MR, Covinsky KE, et al. Why isn\u2019t warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med. 1996;11:721\u20138.","journal-title":"J Gen Intern Med"},{"key":"40_CR34","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0149-2918(03)80167-4","volume":"25","author":"CP Gross","year":"2003","unstructured":"Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians\u2019 reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther. 2003;25:1750\u201364.","journal-title":"Clin Ther"},{"key":"40_CR35","first-page":"927","volume":"131","author":"AS Go","year":"1999","unstructured":"Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927\u201334.","journal-title":"Ann Intern Med"},{"key":"40_CR36","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864\u201370.","journal-title":"JAMA"},{"key":"40_CR37","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","volume":"27","author":"L Friberg","year":"2006","unstructured":"Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-Study on Atrial Fibrillation (SCAF-study). Eur Heart J. 2006;27:1954\u201364.","journal-title":"Eur Heart J"},{"key":"40_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2010.08.056","volume":"299","author":"S Mehrabian","year":"2010","unstructured":"Mehrabian S, Duron E, Labouree F, Rollot F, Bune A, Traykov L, Hanon O. Relationship between orthostatic hypotension and cognitive impairment in the elderly. J Neurol Sci. 2010;299:45\u20138.","journal-title":"J Neurol Sci"},{"key":"40_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11239-006-5633-2","volume":"21","author":"A Ingelg\u00e5rd","year":"2006","unstructured":"Ingelg\u00e5rd A, Hollowell J, Reddy P, Gold K, Tran K, Fitzmaurice D. What are the barriers to warfarin use in atrial fibrillation? Development of a questionnaire. J Thromb Thrombolysis. 2006;21:257\u201365.","journal-title":"J Thromb Thrombolysis"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0040-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-013-0040-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-013-0040-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T16:50:23Z","timestamp":1563641423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-013-0040-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,13]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s40256-013-0040-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2013,8,13]]}}}